Matches in Nanopublications for { ?s ?p "[An RHDV-VLP, modified to contain the universal helper T cell epitope PADRE and decorated with an MHC I-restricted peptide (aa 48-57) from the HPV16 E6, was tested for its immunotherapeutic efficacy against the TC-1 HPV16 E6 and E7-expressing tumour in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP292586.RAe3Hj-YaPfpBYb5ymgxJgCuOcv-OXl_0yi3XgneONtUA130_assertion description "[An RHDV-VLP, modified to contain the universal helper T cell epitope PADRE and decorated with an MHC I-restricted peptide (aa 48-57) from the HPV16 E6, was tested for its immunotherapeutic efficacy against the TC-1 HPV16 E6 and E7-expressing tumour in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292586.RAe3Hj-YaPfpBYb5ymgxJgCuOcv-OXl_0yi3XgneONtUA130_provenance.
- NP875865.RADoKvVhqt7abYlQWqGSy_95sUsvZR5NBRI1hX5GFOJR8130_assertion description "[An RHDV-VLP, modified to contain the universal helper T cell epitope PADRE and decorated with an MHC I-restricted peptide (aa 48-57) from the HPV16 E6, was tested for its immunotherapeutic efficacy against the TC-1 HPV16 E6 and E7-expressing tumour in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875865.RADoKvVhqt7abYlQWqGSy_95sUsvZR5NBRI1hX5GFOJR8130_provenance.
- NP802206.RAi3oRTD2AmJM8hqaYKbgpWjOwvSyvNXmPRd9-LRjrw4M130_assertion description "[An RHDV-VLP, modified to contain the universal helper T cell epitope PADRE and decorated with an MHC I-restricted peptide (aa 48-57) from the HPV16 E6, was tested for its immunotherapeutic efficacy against the TC-1 HPV16 E6 and E7-expressing tumour in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802206.RAi3oRTD2AmJM8hqaYKbgpWjOwvSyvNXmPRd9-LRjrw4M130_provenance.
- NP630060.RA8sMM8ZN0NgOcTwB_clGK3MlkEBrTgMPYG_1LbwNc9x8130_assertion description "[An RHDV-VLP, modified to contain the universal helper T cell epitope PADRE and decorated with an MHC I-restricted peptide (aa 48-57) from the HPV16 E6, was tested for its immunotherapeutic efficacy against the TC-1 HPV16 E6 and E7-expressing tumour in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630060.RA8sMM8ZN0NgOcTwB_clGK3MlkEBrTgMPYG_1LbwNc9x8130_provenance.